A new report by MarketsandMarkets predicts strong growth ahead for the global pharmacogenomics market. The market was valued at $3.5 billion in 2023 and is expected to reach $5.8 billion by 2028, reflecting a compound annual growth rate (CAGR) of 10.6% during this period. Pharmacogenomics refers to the study of how genes affect a person's response to drugs. This field combines pharmacology and...